RAPP

Rapport Therapeutics Inc

$33.15

0.13 (0.39%) Today

— up— down

Market Cap

$1.58B+11.4%

Net Income (TTM)

$-145,407,983

$-145,407,983

EPS (TTM)

-3.04

-3.04

Shares Out

47.83M

47.83M

Open

$33.17

$33.17

Previous Close

$33.02

$33.02

Day Range

$32.62 – $33.57

$32.62 – $33.57

52-Week Range

$23.75 – $52.93

$23.75 – $52.93

Beta

1.90

1.90

Volume

210.26K

210.26K

Avg Volume

373.22K

373.22K

Analyst Rating

Buy

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

NASDAQ NMS - GLOBAL MARKET

About RAPP

Related

News

Rapport: Bipolar Mania Readout May Distort True Value Of Anti-Seizure Med - Rating Upgrade

SeekingAlpha · 6d ago

Rapport Therapeutics, Inc. (RAPP) Discusses RAP-219 Phase II Trial and Unmet Needs in Bipolar Mania - Slideshow

SeekingAlpha · 6d ago

The Zacks Analyst Blog Highlights Kodiak Sciences, Celldex Therapeutics, Rapport Therapeutics and Vaxcyte

Yahoo · 1w ago

Rapport Therapeutics: Great CNS Science, But The Valuation Prices In Significant Success

SeekingAlpha · 1w ago